Mingqing Cai
5Patents
2h-index
13Co-inventors
40Inventor score
Filing activity: Nov 15, 2011 → Mar 31, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9249217B2 | Bispecific EGFRvIII x CD3 antibody engaging molecules | Chemistry; Metallurgy | 6 | Active |
| US10053514B2 | Human bispecific EGFRvIII and CD3 antibody engaging molecules | Chemistry; Metallurgy | 2 | Active |
| US12338284B2 | Binder against programmed death-ligand and application thereof | Physics | 0 | Active |
| US10981983B2 | Antibody targeting interleukin 17A and preparation method and application thereof | Physics | 0 | Active |
| US12269885B2 | Anti-PD-L1/VEGF bifunctional antibody and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.